Form 4: Zeo ScientifiX Interim CEO Acquires Stock Options
SEC Form 4 Filing
Ian T. Bothwell, Interim CEO & CFO of Zeo ScientifiX, Inc., reports the acquisition of stock options.
Summary
- Ian T. Bothwell, the Interim CEO & CFO of Zeo ScientifiX, Inc. filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on July 11, 2024.
- Bothwell acquired 125,000 stock options with an exercise price of $2.35.
- These options vest in equal monthly installments over 18 months from the grant date and expire on July 11, 2034.
- The stock options are granted under the issuer's 2021 Equity Incentive Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by the CEO suggests confidence, but it's a routine transaction.
Positives
- The acquisition of stock options by the Interim CEO & CFO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Stock option grants are a common form of executive compensation, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the stock option transaction. |
| 07/11/2024 | Date the options begin vesting. |
| 08/11/2024 | Date of first vesting installment. |
| 07/15/2024 | Date of the Form 4 filing. |
| 07/11/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.